IBOV 174,576.80 ▲ 1.55% IPSA 11,450.75 ▼ 0.76% IPC MEX 66,293.07 ▲ 0.79% MERVAL 3,009,029 — 0.00% COLCAP 2,508.47 ▼ 0.09% BVL PERÚ 60,117.56 ▲ 0.55% USD/BRL5.16▲ 0.16% USD/MXN16.96▲ 0.05% USD/CLP916.52▲ 0.35% USD/COP3,121▲ 1.87% USD/PEN3.35▼ 0.10% USD/ARS1,512▲ 0.02% USD/UYU40.18▲ 1.06% USD/PYG5,968▲ 0.82% USD/BOB11.50▲ 1.47% USD/DOP58.02▼ 0.50% USD/CRC448.82▲ 1.76% USD/GTQ7.62▲ 2.02% USD/HNL26.82▲ 1.52% USD/NIO36.62▲ 0.09% USD/VES785.55▲ 0.19% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 0.97% EUR/BRL6.01▲ 0.03% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 174,576.80 ▲ 1.55% IPSA 11,450.75 ▼ 0.76% IPC MEX 66,293.07 ▲ 0.79% MERVAL 3,009,029 — 0.00% COLCAP 2,508.47 ▼ 0.09% BVL PERÚ 60,117.56 ▲ 0.55% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Wednesday, August 26, 2026

Brazilian vaccine against drugs is a finalist of international award

By · June 1, 2023 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

By Vitor Marcolin

Researchers from the Federal University of Minas Gerais (UFMG) have developed a vaccine against crack and cocaine addiction that was nominated for the Euro Award due to its importance in the fight against drug addiction.

This award recognizes the innovation potential of Latin American professionals working in medicine.

The Brazilian vaccine was baptized “Calixcoca” and has already proven its safety and efficacy in pre-clinical tests.

Now, the drug is waiting for funding for human trials.

The goal of the vaccine is to block the absorption of cocaine and its derivatives, such as crack (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

HOW THE VACCINE WORKS

Calixcoca was developed to act on the immune system of chemical dependents, inducing the production of antibodies that bind to cocaine in the bloodstream.

This chemical bond transforms the drug into a large molecule unable to pass through the blood-brain barrier.

The goal of the vaccine is to block the absorption of cocaine and its derivatives, such as crack.

Frederico Garcia, a researcher at the Mental Health Department of the School of Medicine (FM-UFMG), said, “This is a prevalent, vulnerable problem for which there is no specific treatment.”

“Our pre-clinical studies prove the safety and efficacy of the vaccine in its application.”

“Our vaccine gives patients suffering from chemical dependency the possibility of returning to social life to realize their dreams”.

PURPOSE OF THE VACCINE

According to Garcia, the goal of Calixcoca, a drug that began to be developed in 2015, is to prevent addiction “relapse” in patients under treatment, “allowing them more time to rebuild their lives away from drugs.”

So far, the medical project has been entirely funded by public funds.

Initially, the scientists tested the substance in pregnant rats, and, according to the results, the vaccine prevented cocaine and crack from reaching the placenta or the fetus of the mammals.

Calixcoca’s patent has already been applied for by UFMG’s Coordination of Technological Transfer and Innovation (CTIT).

With information from Revista Oeste

News Brazil, English news Brazil, Brazilian technology

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.